Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Adagio Therapeutics stock
Learn how to easily invest in Adagio Therapeutics stock.
Adagio Therapeutics wrapped its initial public offering, raising $309.4 million after selling 18.2 million shares at $17 each, right in the middle of its $16 to $18 range.
Shares of ADGI will begin trading later this afternoon, but shares are available for limit orders on Robinhood and other platforms.
How to buy shares in Adagio Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ADGI – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Adagio Therapeutics stock price (NASDAQ: ADGI)Use our graph to track the performance of ADGI stocks over time.
Adagio Therapeutics shares at a glance
|Latest market close||$3.24|
|52-week range||$2.41 - $53.72|
|50-day moving average||$4.11|
|200-day moving average||$4.65|
|Wall St. target price||$3.83|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.63|
Buy Adagio Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Adagio Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Adagio Therapeutics price performance over time
|1 week (2022-09-28)||2.53%|
|1 month (2022-09-02)||-32.22%|
|3 months (2022-07-05)||-3.86%|
|6 months (2022-04-01)||N/A|
|1 year (2021-10-05)||-89.83%|
|2 years (2020-10-01)||N/A|
|3 years (2019-10-01)||N/A|
|5 years (2017-10-01)||N/A|
Adagio Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-37.19%|
|Return on equity TTM||-68.48%|
|Market capitalisation||$505 million|
TTM: trailing 12 months
Adagio Therapeutics share dividends
We're not expecting Adagio Therapeutics to pay a dividend over the next 12 months.
You may also wish to consider:
- Sanofi ADR (SNY.US) (4.59% forward annual dividend yield)
Adagio Therapeutics overview
Adagio Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was incorporated in 2020 and is based in Waltham, Massachusetts. .
Adagio Therapeutics in the news
Invivyd Announces Multiple Next Generation COVID-19 Antibody Candidates and Selects Combination for Clinical Advancement Based on Positive in vitro Data Against Omicron Variants
Adagio Therapeutics Announces Corporate Name Change to Invivyd
Adagio Therapeutics to Participate in Upcoming Investor Conferences
Frequently asked questionsWhat percentage of Adagio Therapeutics is owned by insiders or institutions?
Currently 32.79% of Adagio Therapeutics shares are held by insiders and 71.591% by institutions. How many people work for Adagio Therapeutics?
Latest data suggests 101 work at Adagio Therapeutics. When does the fiscal year end for Adagio Therapeutics?
Adagio Therapeutics's fiscal year ends in December. Where is Adagio Therapeutics based?
Adagio Therapeutics's address is: 1601 Trapelo Road, Waltham, MA, United States, 02451 What is Adagio Therapeutics's ISIN number?
Adagio Therapeutics's international securities identification number is: US00534A1025 What is Adagio Therapeutics's CUSIP number?
Adagio Therapeutics's Committee on Uniform Securities Identification Procedures number is: 019483106
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert